Loading...
Loading...
In the last 30-day frame, the company witnessed one negative estimate revisions while the Zacks Consensus Estimate remained unchanged. Yesterday's price rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Rite Aid currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include ANI Pharmaceuticals, Inc. ANIP, ZIOPHARM Oncology, Inc. ZIOP and Alexion Pharmaceuticals, Inc. ALXN. While ANI Pharmaceuticals and ZIOPHARM Oncology sport a Zacks Rank #1 (Strong Buy), ALexion carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ALEXION PHARMA ALXN: Free Stock Analysis Report
ANI PHARMACEUT ANIP: Free Stock Analysis Report
RITE AID CORP RAD: Free Stock Analysis Report
ZIOPHARM ONCLGY ZIOP: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in